Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach

详细信息    查看全文

• 作者：Neisha Sundaram ; Christian Schaetti ; Sonja Merten ; Christian Schindler…
• 关键词：Vaccine acceptance ; Cholera vaccine ; Social determinants ; Cultural epidemiology ; Meta ; analysis ; Africa
• 刊名：BMC Public Health
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：16
• 期：1
• 全文大小：738 KB
• 参考文献：1.Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012;379:2466–76.PubMed PubMedCentral CrossRef
  2.Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet. 2004;363:223–33.PubMed CrossRef
  3.Ali M, Lopez AL, You YA, Kim YE, Sah B, Maskery B, et al. The global burden of cholera. Bull World Health Organ. 2012;90:209–218A.PubMed PubMedCentral CrossRef
  4.WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. Progress on drinking water and sanitation: 2012 update. United States of America: UNICEF and World Health Organization; 2012. ISBN: 978-92-806-4632-0 (NLM classification: WA 670). http://​www.​who.​int/​water_​sanitation_​health/​publications/​jmp_​report-2012/​en/​ .
  5.World Health Organization. Cholera, 2011. Wkly Epidemiol Rec. 2012;87:289–304.
  6.Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5:e1289.PubMed PubMedCentral CrossRef
  7.Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, et al. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis. 2012;12:837–44.PubMed CrossRef
  8.Feldman-Savelsberg P, Ndonko FT, Schmidt-Ehry B. Sterilizing vaccines or the politics of the womb: retrospective study of a rumor in Cameroon. Med Anthropol Q. 2000;14:159–79.PubMed CrossRef
  9.Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med. 2007;4:e73.PubMed PubMedCentral CrossRef
  10.Kaler A. Health interventions and the persistence of rumour: the circulation of sterility stories in African public health campaigns. Soc Sci Med. 2009;68:1711–9.PubMed CrossRef
  11.Streefland PH. Public doubts about vaccination safety and resistance against vaccination. Health Policy. 2001;55:159–72.PubMed CrossRef
  12.Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32:2150–9.PubMed CrossRef
  13.World Health Organization. Global vaccine action plan 2011–2020. 2013. http://​www.​who.​int/​immunization/​global_​vaccine_​action_​plan/​en/​ . Accessed 15 July 2015.
  14.Alliance GTV. Vaccine investment strategy. 2015. http://​www.​gavi.​org/​about/​strategy/​vaccine-investment-strategy/​ . Accessed 15 July 2015.
  15.Sundaram N, Schaetti C, Chaignat CL, Hutubessy R, Nyambedha EO, Mbonga LA, et al. Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya. Epidemiol Infect. 2013;141:639–50.PubMed PubMedCentral CrossRef
  16.Schaetti C, Chaignat CL, Hutubessy R, Khatib AM, Ali SM, Schindler C, et al. Social and cultural determinants of anticipated acceptance of an oral cholera vaccine prior to a mass vaccination campaign in Zanzibar. Hum Vaccin. 2011;7:1299–308.PubMed CrossRef
  17.Merten S, Schaetti C, Manianga C, Lapika B, Chaignat CL, Hutubessy R, et al. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province. Democratic Republic of Congo BMC Public Health. 2013;13:60.PubMed CrossRef
  18.Schaetti C, Sundaram N, Merten S, Ali SM, Nyambedha EO, Lapika B, et al. Comparing sociocultural features of cholera in three endemic African settings. BMC Med. 2013;11:206.PubMed PubMedCentral CrossRef
  19.World Health Organization. Cholera: global surveillance summary, 2008. Wkly Epidemiol Rec. 2009;84:309–24.
  20.World Health Organization. Cholera, 2009. Wkly Epidemiol Rec. 2010;85:293–308.
  21.Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007;7:521–30.PubMed CrossRef
  22.WHO. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85:117–28.
  23.Weiss MG. Explanatory Model Interview Catalogue (EMIC): Framework for comparative study of illness. Transcult Psychiatry. 1997;34:235–63.CrossRef
  24.Weiss MG. Cultural epidemiology: an introduction and overview. Anthropol Med. 2001;8:5–29.CrossRef
  25.Schaetti C, Hutubessy R, Ali SM, Pach A, Weiss MG, Chaignat CL, et al. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance. BMC Public Health. 2009;9:99.PubMed PubMedCentral CrossRef
  26.Higgins JPT, Green S (editors): Analysing data and undertaking meta-analyses. In Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from www.​cochrane-handbook.​org . Accessed 30 December 2014.
  27.Schaetti C, Khatib A, Ali S, Hutubessy R, Chaignat CL, Weiss M. Social and cultural features of cholera and shigellosis in peri-urban and rural communities of Zanzibar. BMC Infect Dis. 2010;10:339.PubMed PubMedCentral CrossRef
  28.Clemens J, Holmgren J. When, How, and Where can Oral Cholera Vaccines be Used to Interrupt Cholera Outbreaks? Curr Top Microbiol Immunol. 2014;379:231–58.PubMed
  29.Sack DA. A new era in the history of cholera: the road to elimination. Int J Epidemiol. 2013;42:1537–40.PubMed CrossRef
  30.Martin S, Lopez AL, Bellos A, Deen J, Ali M, Alberti K, et al. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ. 2014;92:881–93.PubMed PubMedCentral CrossRef
  31.World Bank. Africa development indicators 2012/2013. Washington, DC: World Bank; 2013. doi: 10.​1596/​978-0-8213-9616-2 .CrossRef
  32.World Health Organization. WHO guide to identifying the economic consequences of disease and injury. Geneva, Switzerland: World Health Organization; 2009. ISBN 978 92 4 159829 3 (NLM classification: WA 30).
  33.Chisholm D, Stanciole AE, Tan Torres ET, Evans DB. Economic impact of disease and injury: counting what matters. BMJ. 2010;340:c924.PubMed CrossRef
  34.Zwisler G, Simpson E, Moodley M. Treatment of diarrhea in young children: results from surveys on the perception and use of oral rehydration solutions, antibiotics, and other therapies in India and Kenya. J Glob Health. 2013;3:10403.CrossRef
  35.Wahed T, Kaukab SS, Saha NC, Khan IA, Khanam F, Chowdhury F, et al. Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh. BMC Public Health. 2013;13:242.PubMed PubMedCentral CrossRef
  36.Shultz A, Omollo JO, Burke H, Qassim M, Ochieng JB, Weinberg M, et al. Cholera outbreak in Kenyan refugee camp: risk factors for illness and importance of sanitation. Am J Trop Med Hyg. 2009;80:640–5.PubMed
  37.Paterson P, Larson HJ. The role of publics in the introduction of new vaccines. Health Policy Plan. 2012;27 Suppl 2:ii77–9.PubMed PubMedCentral CrossRef
  38.Yahya M. Polio vaccines - ‘no thank you!’ barriers to polio eradication in Northern Nigeria. Afr Aff. 2007;106:185–204.CrossRef
  39.World Health Organization. Cholera, 2012. Wkly Epidemiol Rec. 2013;88:321–36.
  40.World Health Organization Regional Office for Africa. Urgent Resolve to end Cholera Outbreak in Kenya. Press material, 23 May 2015. http://​www.​afro.​who.​int/​en/​kenya/​press-materials/​item/​7696-urgent-resolve-to-end-cholera-outbreak-in-kenya.​html . Accessed 20 September 2015.
  
• 作者单位：Neisha Sundaram (1) (2) (3)
  Christian Schaetti (1) (2)
  Sonja Merten (1) (2)
  Christian Schindler (1) (2)
  Said M. Ali (4)
  Erick O. Nyambedha (5)
  Bruno Lapika (6)
  Claire-Lise Chaignat (7)
  Raymond Hutubessy (8)
  Mitchell G. Weiss (1) (2)
  
  1. Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002, Basel, Switzerland
  2. University of Basel, Petersplatz 1, 4003, Basel, Switzerland
  3. Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, Singapore, 117549, Singapore
  4. Public Health Laboratory Ivo de Carneri, Chake-Chake, Pemba, Zanzibar, United Republic of Tanzania
  5. Department of Sociology and Anthropology, Maseno University, Private Bag, Maseno, Kenya
  6. Department of Anthropology, University of Kinshasa, Kinshasa, Democratic Republic of Congo
  7. Global Task Force on Cholera Control, World Health Organization, 20, Avenue Appia, 1211, Geneva 27, Switzerland
  8. Initiative for Vaccine Research, World Health Organization, 20, Avenue Appia, 1211, Geneva 27, Switzerland
  
• 刊物主题：Public Health; Medicine/Public Health, general; Epidemiology; Environmental Health; Biostatistics; Vaccine;
• 出版者：BioMed Central
• ISSN：1471-2458

文摘

Background Controlling cholera remains a significant challenge in Sub-Saharan Africa. In areas where access to safe water and sanitation are limited, oral cholera vaccine (OCV) can save lives. Establishment of a global stockpile for OCV reflects increasing priority for use of cholera vaccines in endemic settings. Community acceptance of vaccines, however, is critical and sociocultural features of acceptance require attention for effective implementation. This study identifies and compares sociocultural determinants of anticipated OCV acceptance across populations in Southeastern Democratic Republic of Congo, Western Kenya and Zanzibar.